32111883|t|Amylin and pramlintide modulate gamma-secretase level and APP processing in lipid rafts.
32111883|a|A major characteristic of Alzheimer's disease (AD) is the accumulation of misfolded amyloid-beta (Abeta) peptide. Several studies linked AD with type 2 diabetes due to similarities between Abeta and human amylin. This study investigates the effect of amylin and pramlintide on Abeta pathogenesis and the predisposing molecular mechanism(s) behind the observed effects in TgSwDI mouse, a cerebral amyloid angiopathy (CAA) and AD model. Our findings showed that thirty days of intraperitoneal injection with amylin or pramlintide increased Abeta burden in mice brains. Mechanistic studies revealed both peptides altered the amyloidogenic pathway and increased Abeta production by modulating amyloid precursor protein (APP) and gamma-secretase levels in lipid rafts. In addition, both peptides increased levels of B4GALNT1 enzyme and GM1 ganglioside, and only pramlintide increased the level of GM2 ganglioside. Increased levels of GM1 and GM2 gangliosides play an important role in regulating amyloidogenic pathway proteins in lipid rafts. Increased brain Abeta burden by amylin and pramlintide was associated with synaptic loss, apoptosis, and microglia activation. In conclusion, our findings showed amylin or pramlintide increase Abeta levels and related pathology in TgSwDI mice brains, and suggest that increased amylin levels or the therapeutic use of pramlintide could increase the risk of AD.
32111883	0	6	Amylin	Gene	15874
32111883	76	81	lipid	Chemical	MESH:D008055
32111883	115	134	Alzheimer's disease	Disease	MESH:D000544
32111883	136	138	AD	Disease	MESH:D000544
32111883	173	185	amyloid-beta	Gene	351
32111883	187	192	Abeta	Gene	351
32111883	226	228	AD	Disease	MESH:D000544
32111883	234	249	type 2 diabetes	Disease	MESH:D003924
32111883	278	283	Abeta	Gene	351
32111883	288	293	human	Species	9606
32111883	294	300	amylin	Gene	3375
32111883	340	346	amylin	Gene	3375
32111883	366	371	Abeta	Gene	11820
32111883	467	472	mouse	Species	10090
32111883	476	503	cerebral amyloid angiopathy	Disease	MESH:D016657
32111883	505	508	CAA	Disease	MESH:D016657
32111883	514	516	AD	Disease	MESH:D000544
32111883	595	601	amylin	Gene	3375
32111883	627	632	Abeta	Gene	11820
32111883	643	647	mice	Species	10090
32111883	747	752	Abeta	Gene	11820
32111883	778	803	amyloid precursor protein	Gene	11820
32111883	840	845	lipid	Chemical	MESH:D008055
32111883	900	908	B4GALNT1	Gene	14421
32111883	920	923	GM1	Gene	210582
32111883	981	996	GM2 ganglioside	Chemical	MESH:D005678
32111883	1018	1021	GM1	Gene	210582
32111883	1026	1042	GM2 gangliosides	Chemical	MESH:D005678
32111883	1114	1119	lipid	Chemical	MESH:D008055
32111883	1143	1148	Abeta	Gene	11820
32111883	1159	1165	amylin	Gene	3375
32111883	1202	1215	synaptic loss	Disease	MESH:D012183
32111883	1289	1295	amylin	Gene	3375
32111883	1320	1325	Abeta	Gene	11820
32111883	1365	1369	mice	Species	10090
32111883	1405	1411	amylin	Gene	3375
32111883	1484	1486	AD	Disease	MESH:D000544
32111883	Positive_Correlation	11820	3375
32111883	Association	MESH:D008055	210582
32111883	Association	MESH:D000544	351
32111883	Association	MESH:D005678	MESH:D008055
32111883	Positive_Correlation	MESH:D000544	3375
32111883	Positive_Correlation	MESH:D012183	11820
32111883	Positive_Correlation	MESH:D012183	3375
32111883	Association	MESH:D008055	11820

